Recent Patents on Anti-Cancer Drug Discovery

Potential Therapeutic Targets of Curcumin, Most Abundant Active Compound of Turmeric Spice: Role in the Management of Various Types of Cancer

Volume: 16   Issue: 1
Pp: 3-29
Saleh A. Almatroodi, Mansoor Ali Syed and Arshad Husain Rahmani*
DOI: 10.2174/1574892815999201102214602

The Anti-Proliferative Effect of a Newly-Produced Anti-PSCA-Peptide Antibody by Multiple Bioinformatics Tools, on Prostate Cancer Cells

Volume: 16   Issue: 1
Pp: 73-83
Milad Chizari, Sajad Fani-Kheshti, Jaleh Taeb, Mohammad M. Farajollahi* and Monireh Mohsenzadegan*
DOI: 10.2174/1574892815999201110212411

Next Generation Sequencing in the Management of Leptomeningeal Metastases of Non-Small Cell Lung Cancer: A Case Report and Literature Review

Volume: 16   Issue: 1
Pp: 108-116
Shuo Li*, Linping Ke*, Xue Meng, Haiyan Zhou, Xiqin Zhang, Huaguo Wu, Jinming Yu* and Hui Zhang*
DOI: 10.2174/1574892815666201127114224

Anti-EGFR-mAb and 5-Fluorouracil Conjugated Polymeric Nanoparticles for Colorectal Cancer

Volume: 16   Issue: 1
Pp: 84-100
Sankha Bhattacharya*
DOI: 10.2174/1574892815666201221121859

Combining PD-1 Inhibitor with VEGF/VEGFR2 Inhibitor in Chemotherapy: Report of a Patient with End-Stage Cholangiocarcinoma and Review of Literature

Volume: 16   Issue: 1
Pp: 101-107
Zhenjiang Ma, Heping Li and Liangshuai Liu*
DOI: 10.2174/1574892815999201231215311

Immunological Mechanism and Clinical Application of PAMP Adjuvants

Volume: 16   Issue: 1
Pp: 30-43
Yu Yan, Dan Yao and Xiaoyu Li*
DOI: 10.2174/1574892816666210201114712

Effect of PI3K/AKT/mTOR Signaling Pathway on Regulating and Controlling the Anti-Invasion and Metastasis of Hepatoma Cells by Bufalin

Volume: 16   Issue: 1
Pp: 54-65
Xia Sheng, Pengfei Zhu, Yi Zhao, Jinwei Zhang, Haijia Li, Huan Zhao and Jianmin Qin*
DOI: 10.2174/1574892816666210201120324

Expression and Clinical Significance of Microtubule-Actin Cross-Linking Factor 1 in Serous Ovarian Cancer

Volume: 16   Issue: 1
Pp: 66-72
Longyang Liu, Ke Hu, Zhaoyang Zeng, Caiqiu Xu, Jin Lv, Zhongqiu Lin and Bin Wen*
DOI: 10.2174/1574892816666210211091543

Construction and Validation of a Nomogram for Predicting Progression- Free Survival in Patients with Early-Stage Testicular Germ Cell Tumor

Volume: 16   Issue: 1
Pp: 44-53
Jin-Guo Chen, Jing-Quan Wang, Tian-Wen Peng, Zhe-Sheng Chen* and Shan-Chao Zhao*
DOI: 10.2174/1574892816666210211092108

Preface promotion: free to download

Volume: 16   Issue: 1
Pp: 1-1
Zhe-Sheng (Jason) Chen
DOI: 10.2174/157489281601210324142034

Meet Our Associate Editorial Board Member promotion: free to download

Volume: 16   Issue: 1
Pp: 2-2
Shanzhi Wang
DOI: 10.2174/157489281601210324142135

Patent Selections: promotion: free to download

Volume: 16   Issue: 1
Pp: 117-117

DOI: 10.2174/157489281601210324152235

Repurposing Chloroquine Analogs as an Adjuvant Cancer Therapy

Volume: 16   Issue:
Pp: 1-17
Winnie Fong and Kenneth K.W. To*
DOI: 10.2174/1574892815666210106111012

Pemetrexed – First-Line Therapy for Non-Squamous Non-Small Cell Lung Cancer: A Review of Patent Literature

Volume: 16   Issue:
Pp: 1-17
Pratik Ashwinbhai Vora*, Rakesh Patel and Abhay Dharamsi
DOI: 10.2174/1574892816666210120113256

Induced Fit Docking and Automated QSAR Studies Reveal the ER-α Inhibitory Activity of Cannabis sativa in Breast Cancer

Volume: 16   Issue:
Pp: 1-12
Babatomiwa Kikiowo*, Adewale J. Ogunleye, Opeyemi Iwaloye, Taiwo T. Ijatuyi, Niyi S . Adelakun and Wasiu O. Alashe
DOI: 10.2174/1574892816666210201115359

In Vitro Metabolism of E2, G2: Novel Bile Acid-Coupling Camptothecin Analogues, in Rat Liver Microsomes

Volume: 16   Issue:
Pp: 1-15
Xiangli Zhang, Qin Shen, Yi Wang, Leilei Zhou, Qi Weng and Qingyong Li*
DOI: 10.2174/1574892816666210204122028

Interplay between RNA Methylation Eraser FTO and Writer METTL3 in Renal Clear Cell Carcinoma Patient Survival

Volume: 16   Issue:
Pp: 1-14
Jiaxun Zhao and Lingeng Lu*
DOI: 10.2174/1574892816666210204125155

Chitosan - A Potential Polymer to Prepare Anticancer Drug Delivery Systems: Patent Review

Volume: 16   Issue:
Pp: 1-9
Priyanka Kriplani* and Kumar Guarve
DOI: 10.2174/1574892816666210208230848

Current Status and Prospects of Camrelizumab, A Humanized Antibody Against Programmed Cell Death Receptor 1

Volume: 16   Issue:
Pp: 1-1
Hao Song, Xiaolong Liu, Lu Jiang, Fangrong Li, Rong Zhang and Ping Wang*
DOI: 10.2174/1574892816666210208231744

Targeting Cancer Stem Cells with Repurposed Drugs to Improve Current Therapies

Volume: 16   Issue:
Pp: 1-1
Dunne Fong*, Chase T. Christensen and Marion M. Chan
DOI: 10.2174/1574892816666210208232251